A Trial in Recombinant Human Prourokinase to Treat Acute Pulmonary Embolism

NCT03108833 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

108

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Pulmonary Embolism

Interventions

DRUG: Recombinant Human Prourokinase
DRUG: Alteplase

Sponsor

Tasly Biopharmaceuticals Co., Ltd.